Scarica l'app Stockscreener
46.88
1.62%
-0.77
Dopo l'orario di chiusura:
46.88
Qiagen Nv Borsa (QGEN) Ultime notizie
Qiagen Reports Restricted Stock Unit Grant to Supervisory Board Member - The Globe and Mail
Qiagen discloses RSU vesting and share settlement for board member Eva Pisa - The Globe and Mail
Qiagen Reports Higher Stake by Massachusetts Financial Services in Voting Rights Disclosure - TipRanks
PTA-NVR: QIAGEN N.V.: Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView
Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen N.V. (NYSE:QGEN) Sees Significant Growth in Short Interest - MarketBeat
Qiagen Discloses Executive Equity Award Vesting Under Long-Term Incentive Plan - TipRanks
QIAGEN discloses equity award transaction by CFO Roland Sackers - TipRanks
QIAGEN Reports Supervisory Board Member’s Restricted Stock Unit Release - TipRanks
Qiagen Discloses Manager’s Restricted Stock Unit Vesting and Share Settlement - TipRanks
QIAGEN reports executive equity award vesting under MAR disclosure rules - TipRanks
Qiagen reports executive performance stock unit release and net share settlement - TipRanks
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
Managers' transactions announcement according to article 19 MAR - TradingView
Qiagen N.V. (QGEN) Presents at Morgan Stanley European Healthcare ConferenceSlideshow - Seeking Alpha
Intech Investment Management LLC Invests $3.27 Million in Qiagen N.V. $QGEN - MarketBeat
Qiagen CEO says working with advisers on strategic review (QGEN:NYSE) - Seeking Alpha
Qiagen NV (QGEN) Trading Down 3.11% on Mar 2 - GuruFocus
QIAGEN engages advisors to review strategic alternatives - StreetInsider
getLinesFromResByArray error: size == 0 How Qiagen N.V. stock performs in rate cut cyclesJuly 2025 Outlook & Safe Entry Point Identification - mfd.ru
Qiagen N.V. (QGEN) Stock Report: Potential 10.91% Upside With Strong Buy Ratings - DirectorsTalk Interviews
JPMorgan Chase & Co. Sells 512,299 Shares of Qiagen N.V. $QGEN - MarketBeat
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - Pressetext
Surge in Options Trading Volume for nLight and Qiagen - Intellectia AI
Goldman Sachs Discloses 3.11% Stake in Qiagen via AFM Filing - TipRanks
Release according to Article 40, Section 1 of the WpHG - TradingView
Is Qiagen N.V. in a long term uptrendRate Hike & Daily Market Momentum Tracking - mfd.ru
Vanguard Group Inc. Raises Holdings in Qiagen N.V. $QGEN - MarketBeat
Zacks Research Issues Negative Outlook for Qiagen Earnings - MarketBeat
Total non-current assets of QIAGEN NV – XETR:QIA - TradingView
QGEN Should I Buy - Intellectia AI
Traders Purchase Large Volume of Call Options on Qiagen (NYSE:QGEN) - MarketBeat
Qiagen NV at Citi Global Healthcare Conference Transcript - GuruFocus
Qiagen N.V. (QGEN) Stock Analysis: Exploring a 13.71% Upside Potential in the Diagnostics & Research Sector - DirectorsTalk Interviews
Big Money Moves: Can Qiagen NV ride the EV wave2025 Sector Review & Momentum Based Trading Ideas - baoquankhu1.vn
Contrasting Qiagen (NYSE:QGEN) & Dermata Therapeutics (NASDAQ:DRMA) - Defense World
Jefferies Maintains Qiagen NV(QGEN.US) With Buy Rating, Maintains Target Price $59 - 富途牛牛
MACD Signal: Can Qiagen NV sustain its profitabilityQuarterly Trade Review & Trade Opportunity Analysis Reports - baoquankhu1.vn
Qiagen (NYSE:QGEN) Rating Increased to Buy at Wall Street Zen - MarketBeat
Trend Recap: Should I average down on Qiagen NV stock2025 Retail Activity & Verified Swing Trading Watchlists - baoquankhu1.vn
MFS New Discovery Series's Qiagen NV(QGEN) Holding History - GuruFocus
QIAGEN NV : Barclays gives a Buy rating - marketscreener.com
Qiagen discloses executive share-based compensation transaction - The Globe and Mail
BlackRock Discloses 10.68% Capital Interest and 11.8% Voting Stake in Qiagen - The Globe and Mail
Qiagen N.V.: Why This Quiet Biotech Stock Just Got Loud for US Investors - AD HOC NEWS
Traders Purchase High Volume of Put Options on Qiagen (NYSE:QGEN) - MarketBeat
New Evercode v4 lets labs profile 5M cells, recover 75% more - Stock Titan
Stifel Maintains Qiagen NV(QGEN.US) With Hold Rating, Raises Target Price to $50 - 富途牛牛
Statutory Profit Doesn't Reflect How Good Qiagen's (NYSE:QGEN) Earnings Are - Yahoo Finance
Qiagen NV (QGEN) Shares Down 3.25% on Feb 17 - GuruFocus
Death Cross: What hedge funds are buying Galaxy Payroll Group Limited2025 Historical Comparison & Stock Timing and Entry Methods - baoquankhu1.vn
Qiagen N.V. (QGEN) Stock Analysis: Navigating the Diagnostics & Research Landscape with an 8.90% Potential Upside - DirectorsTalk Interviews
How Qiagen N.V. (QIA) stock expands through international marketsJuly 2025 Update & Accurate Intraday Trade Tips - mfd.ru
Is Qiagen N.V. backed by strong institutional buyingJuly 2025 Review & Daily Stock Momentum Reports - mfd.ru
What are Qiagen N.V.’s recent SEC filings showingSwing Trade & Long-Term Growth Stock Strategies - mfd.ru
Does Qiagen N.V. align with a passive investing strategyPortfolio Update Report & Daily Entry Point Alerts - mfd.ru
Can Qiagen N.V. ride the EV wave2025 Fundamental Recap & Daily Chart Pattern Signals - mfd.ru
What’s next for Qiagen N.V. stockJuly 2025 Summary & Accurate Intraday Trading Signals - mfd.ru
Can Qiagen N.V. sustain its profitabilityIPO Watch & Risk Controlled Daily Trade Plans - mfd.ru
Qiagen’s Greener Lab Automation Push And What It Could Mean For Growth - Sahm
0.04%
0.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):